Lamictal licensed for bipolar disorder

Depressive episodes are one of the symptoms of bipolar disorder
Depressive episodes are one of the symptoms of bipolar disorder

Lamictal (lamotrigine) has had its licence extended to include the treatment of bipolar disorder. Both the tablets and the orodispersible tablets may be used in the prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes.

The exact mechanism of action of lamotrigine in bipolar disease is unknown, but the anticonvulsant’s interaction with voltage-gated sodium channels is thought to be important.

View Lamictal drug record

Further information: GlaxoSmithKline

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases